Loading…
Polymed has signed definitive agreements to acquire a 90% stake in PendraCare Group (PendraCare Holdings and Wellinq Medical) for an enterprise value of ₹188.5 crore (€18.3 million), gaining access to cardiology catheter solutions and regulated markets in Europe and the US.
Poly Medicure Ltd acquired a 90% stake in Netherlands-based PendraCare Group from Wellinq Holdings BV at an enterprise value of ₹188.5 crore (€18.3 million). The balance 10% will be acquired in 2030.